Braintree Laboratories, Inc. Sustainability Profile
Braintree Laboratories, Inc., commonly referred to as Braintree Labs, is a leading player in the biotechnology industry, headquartered in the United States. Founded in 2010, the company has established itself as a pioneer in developing innovative solutions for the pharmaceutical and healthcare sectors. With a strong operational presence across North America and Europe, Braintree Labs focuses on advanced drug delivery systems and biopharmaceutical manufacturing. The company’s core offerings include cutting-edge formulations and customised manufacturing services that set them apart in a competitive market. Braintree Labs is recognised for its commitment to quality and regulatory compliance, achieving significant milestones such as ISO certification and partnerships with major pharmaceutical firms. With a reputation for excellence, Braintree Laboratories continues to drive advancements in biotechnology, positioning itself as a trusted partner in the industry.
DitchCarbon Score
How does Braintree Laboratories, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Braintree Laboratories, Inc.'s score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Braintree Laboratories, Inc.'s reported carbon emissions
Braintree Laboratories, Inc., headquartered in the US, currently does not have specific carbon emissions data available, as indicated by the absence of reported figures. The company is a current subsidiary and may inherit emissions data from its parent organisation, but no specific details have been provided regarding this cascade. In terms of climate commitments, Braintree Laboratories, Inc. has not outlined any specific reduction targets or initiatives. There are no documented science-based targets (SBTi) or other climate pledges that detail their approach to reducing carbon emissions. As a subsidiary, Braintree Laboratories may align with broader corporate sustainability goals set by its parent company, but without explicit data or commitments, the company's individual climate strategy remains unclear.
How Carbon Intensive is Braintree Laboratories, Inc.'s Industry?
How Carbon Intensive is Braintree Laboratories, Inc.'s Location?
Braintree Laboratories, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Braintree Laboratories, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
